Shanghai Historical Cash Flow
| 688085 Stock | 18.10 0.34 1.84% |
Analysis of Shanghai Sanyou cash flow over time is an excellent tool to project Shanghai Sanyou Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 308 M or Depreciation of 36.3 M as it is a great indicator of Shanghai Sanyou ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Shanghai Sanyou Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shanghai Sanyou Medical is a good buy for the upcoming year.
Shanghai |
About Shanghai Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Shanghai balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Shanghai's non-liquid assets can be easily converted into cash.
Shanghai Sanyou Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Shanghai Sanyou Medical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Shanghai Sanyou operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Shanghai Sanyou Medical financial statement analysis. It represents the amount of money remaining after all of Shanghai Sanyou Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Shanghai Sanyou's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Shanghai Sanyou Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai Sanyou Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Shanghai Sanyou's Investments are projected to increase significantly based on the last few years of reporting. The current year's Change In Cash is expected to grow to about 308 M, whereas Change To Inventory is projected to grow to (62.9 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 138.2M | 66.6M | 76.6M | 69.7M | Depreciation | 17.9M | 30.0M | 34.5M | 36.3M |
Shanghai Sanyou cash flow statement Correlations
Click cells to compare fundamentals
Shanghai Sanyou Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Shanghai Sanyou cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (40.4M) | (40.6M) | (55.0M) | (73.6M) | (66.2M) | (62.9M) | |
| Investments | (820.4M) | 356.0M | (25.9M) | 51.3M | 59.0M | 61.9M | |
| Change In Cash | 225.0M | 119.9M | (41.9M) | 255.1M | 293.3M | 308.0M | |
| Depreciation | 10.0M | 15.5M | 17.9M | 30.0M | 34.5M | 36.3M | |
| Capital Expenditures | 30.5M | 91.7M | 138.2M | 66.6M | 76.6M | 69.7M | |
| Total Cash From Operating Activities | 77.5M | 144.9M | 156.0M | 267.4M | 307.5M | 322.9M | |
| Net Income | 118.8M | 186.4M | 191.9M | 129.9M | 149.4M | 109.3M | |
| End Period Cash Flow | 262.5M | 382.3M | 340.4M | 642.7M | 739.1M | 776.1M | |
| Free Cash Flow | 47.1M | 53.3M | 17.8M | 160.8M | 184.9M | 194.1M | |
| Change In Working Capital | (47.2M) | (39.0M) | (51.7M) | 89.9M | 103.4M | 108.6M | |
| Begin Period Cash Flow | 37.5M | 262.5M | 382.3M | 387.9M | 446.1M | 468.4M | |
| Total Cashflows From Investing Activities | (49.6M) | (830.4M) | 12.4M | (156.1M) | (140.5M) | (147.6M) | |
| Other Non Cash Items | 9.7M | 13.0M | 15.3M | 24.3M | 27.9M | 29.3M | |
| Change To Account Receivables | (70.6M) | (32.1M) | (70.1M) | (39.3M) | (45.2M) | (47.5M) | |
| Change To Operating Activities | 2.4M | 2.9M | 4.0M | 773.9K | 696.5K | 661.7K | |
| Total Cash From Financing Activities | (494.9K) | 978.2M | (37.3M) | (41.9M) | (48.2M) | (45.8M) | |
| Other Cashflows From Investing Activities | 2.9M | 20.4M | 16.1M | 8.9M | 10.2M | 9.9M | |
| Change To Netincome | 5.9M | (14.7M) | (34.6M) | (18.2M) | (16.4M) | (15.5M) | |
| Change To Liabilities | 43.6M | 23.9M | 71.7M | 42.7M | 49.1M | 38.7M |
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
The Cash Flow Statement is a financial statement that shows how changes in Shanghai balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Shanghai's non-liquid assets can be easily converted into cash.